The Debridement To Treat The Traumatic Corneal Abrasion

Corneal Abrasion Clinical Trial

Official title: A Prospective, Randomized, Double-blind, Controlled Clinical Study of Corneal Debridement to Treat the Traumatic Corneal Abrasion

Status Not yet recruiting

Clinical Trial Summary

Patients who signed informed consent to participate in the study will receive corneal epithelial deplasia. The patient was instructed to follow up closely in the following year, and the recurrence of the patient was collected through wechat follow-up.

Clinical Trial Description

Traumatic corneal abrasion (TCA) refers to the injury or defect of the corneal epithelium caused by a foreign object (such as a nail, a tree branch, etc.), which is characterized by severe eye pain accompanied by red eyes, blepharospasm, photophobia, tearing, and a distinct foreign body sensation. TCA is one of the common eye injuries and ophthalmic emergencies, accounting for about 5%-10% in ophthalmic emergencies. Methods: The investigators conducted a clinical trial in adult patients with corneal trauma at the Zhongshan Ophthalmology Center of Sun Yat-sen University. Patients who signed informed consent to participate in the study were provided with corneal epithelial debridement. Patients were instructed to follow closely for the following year, and a pain log of the patient was collected at the last ophthalmology clinic visit. ;

Related Conditions & MeSH terms

• Corneal Abrasion
• Corneal Injuries

• NCT number: NCT05534217
• Study type: Interventional
• Source: Zhongshan Ophthalmic Center, Sun Yat-sen University
• Contact: Zhaohui Yuan, Doctor's degree
• Phone: 13570961208
• Email: yuanzhaohui.@gzzoc.com
• Status: Not yet recruiting
• Phase: N/A
• Start date: December 31, 2022
• Completion date: January 1, 2024